ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BPMC Blueprint Medicines Corporation

107.00
12.14 (12.80%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
12.14 12.80% 107.00 10:00:00
Open Price Low Price High Price Close Price Previous Close
103.88 100.905 110.1555 107.00 94.86
more quote information »

Recent News

Date Time Source Heading
02/5/202421:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/4/202422:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/4/202422:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
05/4/202407:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
12/3/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
07/3/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:19EDGAR2Form 144 - Report of proposed sale of securities
02/3/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202408:03EDGAR2Form 144 - Report of proposed sale of securities
24/2/202400:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
23/2/202400:20EDGAR2Form 8-K - Current report
17/2/202408:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/2/202409:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202423:05EDGAR2Form 8-K - Current report
15/2/202423:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
15/2/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
02/2/202400:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
30/1/202410:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:13EDGAR2Form 144 - Report of proposed sale of securities
09/1/202400:03EDGAR2Form 8-K - Current report
09/1/202400:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
06/1/202408:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
27/12/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202308:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202300:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
16/12/202308:23EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202300:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
12/12/202309:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202304:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
08/12/202310:09EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock